Related Experiment Video
Updated: May 14, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Resistome Profiling of a Large Collection of Staphylococcus aureus Isolates Uncovers Frameshift-Silenced mupA Gene
Martyna Kasela1, Katarzyna Suśniak1, Mateusz Ossowski2
1Department of Pharmaceutical Microbiology, Medical University of Lublin, 1 Chodźki St., 20-093 Lublin, Poland.
Abstract:
Staphylococcus aureus is a high-priority pathogen causing skin and soft tissue infections (SSTIs). The frequent resistance to anti-staphylococcal agents exhibited by this underscores the need for accurate diagnostics to guide effective therapy. Therefore, this study aimed to compare phenotypic and genotypic resistance in S. aureus isolates from nasal carriers and SSTIs and to elucidate gene-silencing mechanisms. In total, 355 S. aureus isolates (256 isolated from carriers and 79 from SSTIs) were studied for their phenotypic and genotypic resistance to β-lactams, macrolides, tetracyclines, aminoglycosides, and mupirocin. The silenced mupA gene (low prevalence: 0.6%; 2/335), linked to mupirocin resistance, was sequenced, and expression was assessed via reverse transcription qualitative PCR (RT-qPCR) in all mupA-positive isolates. SSTI isolates showed significantly higher resistance to erythromycin, gentamicin, and mupirocin, along with a higher prevalence of multidrug-resistant strains and ermC and tetM genes. Sequencing revealed multiple mutations in silent mupA, including a critical frameshift (c.372 delA) in a poly(A) tract that brings about premature truncation. RT-qPCR indicated upregulation of silent mupA variants and high variability in functional strains, suggesting that frameshift alone prevents resistance. These findings highlight silent resistance genes as key targets for advancing S. aureus surveillance and for combating emerging threats.
Insights
Silent Staphylococcus aureus resistance genes, particularly mupirocin resistance (mupA), are crucial for surveillance. Frameshift mutations in mupA prevent resistance, highlighting silent genes as targets against emerging threats.
Area of Science:
- Microbiology
- Genetics
- Infectious Diseases
Background:
- Staphylococcus aureus is a high-priority pathogen causing skin and soft tissue infections (SSTIs).
- Frequent antimicrobial resistance necessitates accurate diagnostics for effective therapy.
- Understanding resistance mechanisms, including gene silencing, is critical.
Purpose of the Study:
- Compare phenotypic and genotypic resistance in S. aureus from nasal carriers and SSTIs.
- Investigate gene-silencing mechanisms, focusing on the mupA gene.
- Elucidate the role of mutations in silent resistance genes.
Main Methods:
- Phenotypic and genotypic resistance profiling of 355 S. aureus isolates.
- Sequencing of the silenced mupA gene.
- Reverse transcription quantitative PCR (RT-qPCR) to assess gene expression.
Main Results:
- SSTI isolates showed higher resistance to erythromycin, gentamicin, and mupirocin.
- Higher prevalence of multidrug-resistant strains, ermC, and tetM genes in SSTI isolates.
- Frameshift mutations (e.g., c.372 delA) in silent mupA were identified, leading to premature truncation and preventing resistance.
Conclusions:
- Silent resistance genes represent key targets for S. aureus surveillance.
- Frameshift mutations in mupA suggest a mechanism preventing functional resistance.
- Findings aid in combating emerging antimicrobial resistance threats.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
